Skip to main content Accessibility help
×
Hostname: page-component-78c5997874-fbnjt Total loading time: 0 Render date: 2024-11-18T07:44:23.996Z Has data issue: false hasContentIssue false

19 - Clinical management of viral encephalitis

from Section III - Introduction: immunity, diagnosis, vector, and beneficial uses of neurotropic viruses

Published online by Cambridge University Press:  22 August 2009

Kenneth L. Tyler
Affiliation:
Department of Neurology, Microbiology, and Medicine, University of Colorado at Denver, and Neurology Service, Denver Veterans Affairs Medical Center, Denver, CO, USA
Donald H. Gilden
Affiliation:
Departments of Neurology and Microbiology, University of Colorado School of Medicine, Denver, CO, USA
Carol Shoshkes Reiss
Affiliation:
New York University
Get access

Summary

Introduction

Most cases of viral encephalitis are acute, although a few viruses can cause chronic progressive encephalitis. Rarely, systemic virus infection may trigger post-infectious encephalomyelitis. Viral encephalitis typically reflects viral invasion of the brain parenchyma. Encephalitis patients usually have alterations in their state of consciousness. Some viruses produce “diffuse” encephalitis in which the predominant features are impaired consciousness, signs of generalized central nervous system (CNS) dysfunction such as generalized seizures, and a cerebral spinal fluid (CSF) pleocytosis. Conversely, other viruses produce “focal encephalitis,” in which altered consciousness and CSF abnormalities are accompanied by prominent focal abnormalities on neuroimaging tests or clinical examination including hemiparesis, aphasia, hemisensory loss, ataxia, focal as well as generalized seizures, and, less often, involuntary movements, visual field defects, and cranial nerve deficits. Personality changes, language, and memory disturbances and psychotic features are frequent. Viral encephalitis must be distinguished from nonviral conditions that can present a similar clinical picture, including Lyme disease, tuberculosis, syphilis, Listeria, Mycoplasma, fungal and parasitic infections, brain abscess, subdural hematoma or abscess, brain tumors, CNS vasculitis, and toxic/metabolic encephalopathies.

Viral encephalitis may be epidemic or sporadic (see also Chapter 17). Causes of epidemic viral encephalitis include the togaviruses, enteroviruses (see Chapter 17), mumps and lymphocytic choriomeningitis (LCM) virus (see Chapter 1). The toga-viruses are RNA viruses transmitted by mosquitoes or ticks (arthropod-born) (see Chapters 6, 7, and 20), with a peak incidence in the Northern Hemisphere in the warm summer months.

Type
Chapter
Information
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Breeden, C. J., Hall, T. C., and Tyler, H. R., Ann Intern Med, 65 (1966) 1050–6.CrossRef
Boston Interhospital Virus Study Group, N Engl J Med, 292 (1975) 599–603.CrossRef
Whitley, R. J., Soong, S. J., Dolin, R., et al., N Engl J Med, 297 (1977) 289–94.CrossRef
Whitley, R. J., Soong, S. J., Hirsch, M. S., et al., N Engl J Med, 304 (1981) 313–8.CrossRef
Whitley, R. J., Alford, C. A., Hirsch, M. S., et al., N Engl J Med, 314 (1986) 144–9.CrossRef
Whitley, R. J., Alford, C. A., Hirsch, R. T., et al., Infection, 15 (Suppl 1) (1987) S3–8.CrossRef
Skoldenberg, B., Forsgren, M., Alestig, K., et al., Lancet, 2 (1984) 707–11.CrossRef
Cinque, P., Cleator, G. M., Weber, T., et al., J Neurol Neurosurg Psychiatry, 61 (1996) 339–45.CrossRef
Tyler, K. L., Herpes, 11 (Suppl 2) (2005) 57A–64A.
Steiner, I., Budka, H., Chaudhuri, A., et al., Eur J Neurol, 12 (2005) 33–43.CrossRef
VanLandingham, K. E., Marsteller, B., Ross, G. W., et al., JAMA, 259 (1988) 1051–3.CrossRef
Ito, Y., Kimura, H., Yabuta, Y., et al., Clin Infect Dis, 30 (2000) 185–7.CrossRef
Benson, P. C. and Swadron, S. P., Ann Emerg Med, 47 (2006) 100–5.CrossRef
Gordon, B., Selnes, O. A., Hart, J., et al., Arch Neurol, 47 (1990) 646–7.CrossRef
Perry, C. M. and Faulds, D., Drugs, 52 (1996) 754–72.CrossRef
MacDougall, C. and Guglielmo, B. J., J Antimicrob Chemother, 53 (2004) 899–901.CrossRef
Chan, P. K., Chow, P. C., Mak, A. W., et al., Hong Kong Med J, 6 (2000) 119–21.
Meyding-Lamade, U. K., Oberlinner, C., Rau, P. R., et al., J Neurovirol, 9 (2003) 118–25.CrossRef
Thompson, K. A., Blessing, W. W., and Wesselingh, S. L., J Neurovirol, 6 (2000) 25–32.CrossRef
Nakano, A., Yamasaki, R., Miyazaki, S., et al., Eur Neurol, 50 (2003) 225–9.CrossRef
Kamei, S., Sekizawa, T., Shiota, H., et al., J Neurol Neurosurg Psychiatry, 76 (2005) 1544–9.CrossRef
Wintergerst, U., Kugler, K., Harms, F., et al., Eur J Med Res, 10 (2005) 527–31.
Page, L. K., Tyler, H. R., and Shillito, J., J Neurosurg, 27 (1967) 346–52.CrossRef
Ebel, H., Kuchta, J., Balogh, A., et al., Childs Nerv Syst, 15 (1999) 84–6.CrossRef
Yan, H.-J., Surg Neurol, 57 (2002) 20–4.CrossRef
Kimberlin, D., Herpes, 11 (Suppl 2) (2004) 65A–76A.PubMed
Whitley, R. J., Nahmias, A. J., Soong, S. J., et al., Pediatrics, 66 (1980) 495–501.
Whitley, R. J., Yeager, A., Kartus, P., et al., Pediatrics, 72 (1983) 778–85.
Whitley, R. J., Arvin, A., Prober, C., et al., N Engl J Med, 324 (1991) 444–9.CrossRef
Kimberlin, D. W., Lin, C.-Y., Jacobs, R. F., Powell, D. A., et al., Pediatrics, 108 (2001) 230–8.CrossRef
Kimberlin, D., Powell, D., Gruber, W., et al., Pediatr Infect Dis J, 15 (1996) 247–54.CrossRef
Bergstrom, T. and Alestig, K., Scand J Infect Dis, 22 (1990) 239–40.CrossRef
Berger, J. R., Lancet, 337 (1991) 1360–1.CrossRef
Schlesinger, Y., Tebas, P., Gaudreault-Keener, M., et al., Clin Infect Dis, 20 (1995) 842–8.CrossRef
Kohlhoff, S. A., Marciano, T. A., and Rawstron, S. A., Acta Paediatr, 93 (2004) 1123–4.CrossRef
Mommeja-Marin, H., Lafaurie, M., Scieux, C., et al., Clin Infect Dis, 37 (2003) 1527–33.CrossRef
Tyler, K. L., Tedder, D. G., Yamamoto, L. J., et al., Neurology, 45 (1995) 2246–50.CrossRef
Chu, K., Kang, D. W., Lee, J. J., et al., Arch Neurol, 59 (2002) 460–3.CrossRef
Tang, J. W., Coward, L. J., Davies, N. W., et al., J Neurol Neurosurg Psychiatry, 74 (2003) 1323–5.CrossRef
Nakajima, H., Furutama, D., Kimura, F., et al., Eur Neurol, 39 (1998) 163–7.CrossRef
Gobbi, C., Tosi, C., Stadler, C., et al., Eur Neurol, 46 (2001) 215–8.CrossRef
Eberhardt, O., Kuker, W., Dichgans, J., et al., Neurology, 63 (2004) 758–9.CrossRef
Silva, S. M., Mark, A. S., Gilden, D. H., et al., Neurology, 47 (1996) 929–31.CrossRef
Gilden, D. H., Lipton, H. L., Wolf, J. S., et al., N Engl J Med, 347 (2002) 1500–3.CrossRef
Kronenberg, A., Schupbach, R., Schuknecht, B., et al., Clin Infect Dis, 35 (2002) 330–3.CrossRef
Cohen, B. A., Neurology, 46 (1996) 444–50.CrossRef
Whitley, R. J., Jacobson, M. A., Friedberg, D. N., et al., Arch Intern. Med., 158 (1998) 957–69.CrossRef
Cinque, P., Cleator, G. M., Weber, T., et al., J Neurovirol, 4 (1998) 120–32.CrossRef
Anduze-Faris, B. M., Fillet, A.-M., Gozlan, J., et al., AIDS, 14 (2000) 518–24.CrossRef
Kim, Y. S. and Hollander, H., Clin Infect Dis, 17 (1993) 32–7.CrossRef
Cinque, P., Baldanti, F., Vago, L., et al., J Infect Dis, 171 (1995) 1603–6.CrossRef
Sadler, M., Morris-Jones, S., Nelson, M., et al., AIDS, 11 (1997) 1293–4.CrossRefPubMed
Seo, S. K., Regan, A., Cihlar, T., et al., Clin Infect Dis, 33 (2001) e105–9.CrossRef
Anders, H. J., Weiss, N., Bogner, J. R., et al., J Infect, 36 (1998) 29–33.CrossRef
Tokumoto, J. and Hollander, H., Clin Infect Dis, 17 (1993) 854–6.CrossRef
Smith, I. L., Shinkai, M., Freeman, W. R., et al., J Infect Dis, 173 (1996) 1481–4.CrossRef
Benson, C. A., Kaplan, J. E., Masur, H., et al., Clin Infect Dis, 40 (Suppl 3) (2005) S131–5.CrossRef
Griffiths, P., Herpes, 11 (Suppl 2) (2004) 95A–103A.PubMed
Miller, G. G., Boivin, G., Dummer, J. S., et al., Clin Infect Dis, 42 (2006) e26–9.CrossRef
Julin, J. E., Burik, J. H., Krivit, W., et al., Transpl Infect Dis, 4 (2002) 201–6.CrossRef
Cohen, B. A., McArthur, J. C., Grohman, S., et al., AIDS, 43 (1993) 493–9.PubMed
Spector, S. A., McKinley, G. F., Lalezari, J. P., et al., N Engl J Med, 334 (1996) 1491–7.CrossRef
Berman, S. M. and Kim, R. C., Am J Med, 96 (1994) 415–9.CrossRef
Limaye, A. P., Corey, L., Koelle, D. M., et al., Lancet, 356 (2000) 645–9.CrossRef
Hu, H., Jabs, D. A., Forman, M. S., et al., J Infect Dis, 185 (2002) 861–7.CrossRef
Youle, M. S., Gazzard, B. G., Johnson, M. A., et al., AIDS, 8 (1994) 641–9.CrossRef
Feinberg, J. E., Hurwitz, S., Cooper, D., et al., J Infect Dis, 177 (1998) 48–56.CrossRef
Whitley, R. J., Cloud, G., Gruber, W., et al., J Infect Dis, 175 (1997) 1080–6.CrossRef
Kimberlin, D. W., Lin, C.-Y., Sanchez, P. J., et al., J Pediatr, 143 (2003) 16–25.CrossRef
Mookerjee, B. P. and Vogelsang, G., Bone Marrow Transplant, 20 (1997) 905–6.CrossRef
Nash, P. J., Avery, R. K., Tang, W. H., et al., Am J Transplant, 4 (2004) 1200–3.CrossRef
Cole, P. D., Stiles, J., Boulad, F., et al., Clin Infect Dis, 27 (1998) 653–4.CrossRef
Bethge, W., Beck, R., Jahn, G., et al., Bone Marrow Transplant, 24 (1999) 1245–8.CrossRef
Tiacci, E., Luppi, M., Barozzi, P., et al., Haematologica, 85 (2000) 94–7.
Benito, N., Ricart, M. J., Pumarola, T., et al., Am J Transplant, 4 (2004) 1197–9.CrossRef
Singh, N. and Paterson, D. L., Transplantation, 69 (2000) 2474–9.CrossRef
Yoshihara, S., Kato, R., Inoue, T., et al., Transplantation, 77 (2004) 835–8.CrossRefPubMed
Novoa, L. A., Nagra, R. M., Nakawatase, T., et al., J Med Virol, 52 (1997) 301–8.3.0.CO;2-L>CrossRef
Beovic, B., Pecaric-Meglic, N., Marin, J., et al., Scand J Infect Dis, 33 (2001) 942–4.
Portolani, M., Pecorari, M., Tamassia, M. G., et al., J Med Virol, 65 (2001) 133–7.CrossRef
Birnbaum, T., Padovan, C. S., Sporer, B., et al., Clin Infect Dis, 40 (2005) 887–9.CrossRef
Denes, E., Magy, L., Pradeau, K., et al., Emerg Infect Dis, 10 (2004) 729–31.CrossRef
Zerr, D. M., Gupta, D., Huang, M. L., et al., Clin Infect Dis, 34 (2002) 309–17.CrossRef
Romero, J. R., Exp Opin Invest Drugs, 10 (2001) 369–79.CrossRef
Nath, A. In Johnson, R. T., Griffin, J. W., and McArthur, J. C. (Eds.), Current therapy in neurologic disease, 7th ed., Mosby Elsevier, Philadelphia, 2006, pp. 144–54.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Clinical management of viral encephalitis
    • By Kenneth L. Tyler, Department of Neurology, Microbiology, and Medicine, University of Colorado at Denver, and Neurology Service, Denver Veterans Affairs Medical Center, Denver, CO, USA, Donald H. Gilden, Departments of Neurology and Microbiology, University of Colorado School of Medicine, Denver, CO, USA
  • Edited by Carol Shoshkes Reiss, New York University
  • Book: Neurotropic Viral Infections
  • Online publication: 22 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511541728.024
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Clinical management of viral encephalitis
    • By Kenneth L. Tyler, Department of Neurology, Microbiology, and Medicine, University of Colorado at Denver, and Neurology Service, Denver Veterans Affairs Medical Center, Denver, CO, USA, Donald H. Gilden, Departments of Neurology and Microbiology, University of Colorado School of Medicine, Denver, CO, USA
  • Edited by Carol Shoshkes Reiss, New York University
  • Book: Neurotropic Viral Infections
  • Online publication: 22 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511541728.024
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Clinical management of viral encephalitis
    • By Kenneth L. Tyler, Department of Neurology, Microbiology, and Medicine, University of Colorado at Denver, and Neurology Service, Denver Veterans Affairs Medical Center, Denver, CO, USA, Donald H. Gilden, Departments of Neurology and Microbiology, University of Colorado School of Medicine, Denver, CO, USA
  • Edited by Carol Shoshkes Reiss, New York University
  • Book: Neurotropic Viral Infections
  • Online publication: 22 August 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511541728.024
Available formats
×